Lunai Bioworks Capital Expenditures (CapEx) Growth & History (LNAI)

Lunai Bioworks's capital expenditures (capex) was $70,430 for fiscal 2024.

View full Lunai Bioworks company overview

Lunai Bioworks annual capital expenditures (capex) history

Lunai Bioworks annual capital expenditures (capex)

Fiscal yearPeriod endedCapital expenditures (CapEx)ChangeGrowth
20242024-06-30$70,430$40,656+136.55%
20232023-06-30$29,774$24,618+477.46%
20222022-06-30$5,156−$43,736−89.45%
20212021-06-30$48,892−$135,571−73.49%
20202020-06-30$184,463−$532,206−74.26%
20192019-06-30$716,669$686,669+2288.90%
20182018-06-30$30,000
20132013-12-31$27,548

Lunai Bioworks capital expenditures (capex) trends

Over the last five fiscal years, Lunai Bioworks's capital expenditures (capex) decreased from $716,669 to $70,430, a change of −$646,239. The latest reported quarter, Q3 2026, shows $0.

About the metric

What capital expenditures (CapEx) mean

Capital expenditures, commonly called CapEx, are cash investments in long-lived assets such as property, plants, equipment, infrastructure, and productive software. CapEx can support future growth or maintain existing operations, but it reduces current-period free cash flow.

Calculation and source

SEC-reported capital expenditures

TickerStat standardizes cash payments for property, plant, equipment, and other productive assets reported in company SEC filings. When a filer reports separate qualifying CapEx components instead of a total, those components are combined for the same fiscal period. Fiscal periods can differ from calendar years, so exact period-end dates are included.

Review Lunai Bioworks source filings ↗

Community posts

It’s quiet here.

No posts about LNAI yet. Start the conversation.

Write the first post